Related Experiment Video
Updated: Mar 21, 2026
06:59
A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
Published on: November 9, 2016
31.5K
[Assessing and making safe the medicine use pathway in paediatrics]
Nicolas Didelot1, Catherine Guerrier2, Anne Didelot2
1c/o Soins Pédiatrie-Puériculture, Elsevier Masson, 92442 Issy-les-Moulineaux cedex, France.
Soins. Pediatrie, Puericulture
|May 15, 2016
Summary
Audits of the medicine use pathway in pediatric rehabilitation identified adverse events. The study
Area of Science:
- Pediatric medicine safety
- Medication management systems
- Healthcare quality improvement
Context:
- Adverse events in pediatric follow-up care and rehabilitation units were assessed.
- Audits focused on the complete medicine use pathway.
- Existing assessment methods were reviewed.
Purpose:
- To evaluate the medicine use pathway in pediatric rehabilitation.
- To identify areas for improvement in medication safety.
- To develop a standardized audit tool.
Summary:
- Audits were conducted on the medicine use pathway within a pediatric follow-up care and rehabilitation unit.
- The study assessed adverse events related to medication administration.
- An evaluation grid was developed based on these findings.
Impact:
- The developed evaluation grid is now used for national-level audits of medicine use pathways.
- This contributes to enhancing medication safety standards across healthcare facilities.
- The findings support evidence-based practices in pediatric patient care.
Keywords:
adverse eventauditcircuit du médicamentfollow-up care and rehabilitationmedicine use pathwaypaediatricspédiatriesecuringsoins de suite et de réadaptationsécurisationévénement indésirableMore Related Videos
10:02Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
Published on: March 12, 2020
16.9K
19:15Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
88.4K
Related Concept Videos
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
368
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
368
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
439
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
439
01:26Pharmaceutical Poisoning: Potential Scenarios
57
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
57
01:29Drug Dosing: Infants and Children
705
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
705
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
664
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
664
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
315
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
315